Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy
- PMID: 6297227
- DOI: 10.1007/BF00688612
Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy
Abstract
The reproliferation of glioblastomas after radiation and chemotherapy has been studied in 25 tumors by means of whole mount histological preparations. The tumors have been subdivided into four groups according to the radiation dose and the distance from the end of radiation. After 4,000 rad vessel proliferations and mitoses stop, while vessel degenerations and astrocytes with deformed nuclei appear. Six months after 6,000 rad have been delivered, repopulation phenomena are clearly evident and are mainly represented by mitoses both in parenchyma and in the vessel walls, circumscribed necroses with pseudopalisadings, proliferations of formerly degenerated vessels, etc. The brain adjacent to tumor (BAT) has a great importance since it is one of the reproliferating sites, even though it may be unrecognizable for the occurrence of radiation damages.
Similar articles
-
Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches.Zentralbl Neurochir. 1981;42(2-3):99-119. Zentralbl Neurochir. 1981. PMID: 6267846 No abstract available.
-
Pathology of human malignant gliomas after radiation and chemotherapy.Acta Neurochir (Wien). 1980;53(3-4):205-16. doi: 10.1007/BF02074793. Acta Neurochir (Wien). 1980. PMID: 7424614
-
Malignant astrocytic gliomas in children.Cancer. 1990 Jun 15;65(12):2771-8. doi: 10.1002/1097-0142(19900615)65:12<2771::aid-cncr2820651227>3.0.co;2-j. Cancer. 1990. PMID: 2160318
-
Treatment of recurrent glioblastoma: state-of-the-art and future perspectives.Expert Rev Anticancer Ther. 2020 Sep;20(9):785-795. doi: 10.1080/14737140.2020.1807949. Epub 2020 Sep 3. Expert Rev Anticancer Ther. 2020. PMID: 32799576 Review.
-
NovoTTF-100A: a new treatment modality for recurrent glioblastoma.Expert Rev Neurother. 2012 Aug;12(8):895-9. doi: 10.1586/ern.12.80. Epub 2012 Jun 19. Expert Rev Neurother. 2012. PMID: 22708931 Review.
Cited by
-
Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.J Neurooncol. 1987;4(3):195-207. doi: 10.1007/BF00150611. J Neurooncol. 1987. PMID: 3104548
-
The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas.Neurosurg Rev. 2010 Apr;33(2):193-203; discussion 203-4. doi: 10.1007/s10143-010-0248-7. Epub 2010 Mar 2. Neurosurg Rev. 2010. PMID: 20195675
-
Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.Acta Neuropathol. 1993;85(5):495-502. doi: 10.1007/BF00230488. Acta Neuropathol. 1993. PMID: 8098564
-
The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.J Neurooncol. 2014 Jul;118(3):461-78. doi: 10.1007/s11060-013-1331-z. Epub 2014 Apr 15. J Neurooncol. 2014. PMID: 24733643
-
Vascular response to irradiation in malignant gliomas.J Neurooncol. 1990 Feb;8(1):73-84. doi: 10.1007/BF00182090. J Neurooncol. 1990. PMID: 2319294
References
MeSH terms
Substances
LinkOut - more resources
Medical